Since Jul 2019
AUM managed
₹17,452.98Cr
Tenure
Since Jul 2019
Funds
3
NAV
₹34.23
-0.17% today
AUM
₹1,102.73 Cr
Fund size
Expense
1.90%
Regular plan
Min SIP
₹100
per month
Min Lumpsum
₹1,000
one-time
Exit Load
1.0
on redemption
STCG · short-term
20%Short-term gains taxed at 20%
Applies when equity fund units are sold within 12 months.
LTCG · long-term
12.5%Long-term gains taxed at 12.5%
Applies when equity fund units are sold after 12 months.
Equity-oriented mutual fund taxation applies based on holding period.
Since Jul 2019
AUM managed
₹17,452.98Cr
Tenure
Since Jul 2019
Funds
3
Since Nov 2022
AUM managed
₹1,72,896.45Cr
Tenure
Since Nov 2022
Funds
40
ABSL Pharma & Healthcare Reg Gr is an open-ended Sector - Healthcare mutual fund scheme offered by Aditya Birla Sun Life Mutual Fund under the regular plan with the growth option. Its latest net asset value (NAV) is ₹34.23 per unit and the scheme manages ₹1,102.73 Cr in assets under management. The fund charges an expense ratio of 1.90% and is benchmarked against BSE Healthcare TR INR (100%). Over the trailing 5 years, ABSL Pharma & Healthcare Reg Gr has delivered +11.47% returns. SEBI's riskometer places this scheme in the Very High Risk category, so read the scheme information document before investing.
The scheme provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India. The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes’ objectives will be achieved.
Regular Plan · Growth option · NAV as of 15 Oct 2026
| Period | Fund | Category average |
|---|---|---|
| 1 month | -4.73% | -5.83% |
| 3 months | -4.63% | -3.41% |
| 6 months | +10.78% | +13.35% |
| 1 year | +10.17% | +10.74% |
| 3 years | +17.39% | +19.18% |
| 5 years | +11.47% | +12.83% |
| Period | Fund | Category average |
|---|---|---|
| 1 month | -- | -3.44% |
| 3 months | +11.99% | +1.95% |
| 6 months | +18.51% | +19.58% |
| 1 year | +19.94% | +17.08% |
| 3 years | +79.35% | +73.64% |
| 5 years | +85.87% | +91.32% |
Past performance is not indicative of future returns. Mutual fund investments are subject to market risks; read all scheme related documents carefully.
The latest net asset value (NAV) of ABSL Pharma & Healthcare Reg Gr is ₹34.23 per unit, -0.17% over the previous trading day. NAV is declared by the AMC at the end of every business day.
ABSL Pharma & Healthcare Reg Gr has returned +11.47% over the trailing 5 years (1 year: +10.17%, 3 years: +17.39%). Returns beyond one year are annualised. Past performance does not guarantee future returns.
ABSL Pharma & Healthcare Reg Gr charges an expense ratio of 1.90% per annum. The expense ratio is deducted from the scheme's assets, so the NAV you see is already net of it.
SEBI's riskometer classifies ABSL Pharma & Healthcare Reg Gr as Very High Risk, which is typical for a Sector - Healthcare scheme. Match the scheme's risk level to your own risk tolerance and investment horizon before investing.
You can start a SIP in ABSL Pharma & Healthcare Reg Gr from ₹100 per month, and the minimum lumpsum investment is ₹1,000.
ABSL Pharma & Healthcare Reg Gr is managed by Aditya Birla Sun Life Mutual Fund, holds ₹1,102.73 Cr in assets under management and invests across 39 holdings. This page covers the regular plan with the growth option.
We use cookies
We use cookies to help this site function, understand service usage, and support marketing efforts. Cookie Policy ·